Abstract:The aim of this study was to investigate the effects of angiotensin II (Ang II) on extracellular signal-regulated protein kinase (ERK) signaling pathway in cultured vascular smooth muscle cells (VSMCs) from spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats. VSMCs from SHR and WKY rats were treated with 1x10(-7) mmol/L Ang II for 24 h in the absence or presence of 30 min of pre-treatment of valsartan (1x10(-5) mmol/L) or PD98059 (1x10(-5)mmol/L), selective inhibitor of ERKs- dependent pathways, when they were cultured in 20% calf serum medium. VSMCs of SHR and WKY cultured in serum-free medium were used as control groups. Among the different treatments, VSMCs from the SHR and WKY were devided into four groups: (1) control, (2) Ang II, (3) Ang II + valsartan, (4) Ang II + PD98059. ERK activity in VSMCs was measured by immuno-precipitation. Proteins of total ERK (t-ERK), phosphorylated-ERK (p-ERK) and mitogen-activated protein kinases phosphatase-1 (MKP-1) in VSMCs were detected by Western blot. MKP-1 mRNA in VSMCs was measured by RT-PCR. In VSMCs from WKY or SHR rats, ERK activity, p-ERK, MKP-1 and MKP-1 mRNA in Ang II group were higher than those in control group (P<0.05). In both SHRs and WKYs, there were no significant differences in ERK activity, p-ERK, MKP-1 and MKP-1 mRNA among the control group, Ang II + valsartan group and Ang II + PD98059 group. ERK activity, p-ERK, MKP-1 and MKP-1 mRNA in SHRs were significantly higher than those in WKYs with same treatments (P<0.01). There was no significant difference in t-ERK among different groups and no difference in t-ERK between SHRs and WKYs (P>0.05). Our results show that Ang II activates VSMCs ERK signaling pathways via Ang II type 1 (AT(1)) receptors. Ang II increased ERK activity and p-ERK, but not t-ERK, accompanied by an increase in MKP-1 mRNA expression and protein. Among the different treatments, ERK activity and p-ERK were higher in SHR than in WKY. Valsartan and PD98059 blocked Ang II-stimulated ERK activation. These results suggest that ERK signaling pathway plays an important role in the pathogenesis of hypertension. The effect of Ang II on SHR and WKY VSMCs' ERK signaling pathway may be mediated by AT(1) receptors, enhancing ERK activity and the amount of p-ERK, and then increasing MKP-1 mRNA and its expression.

Angiotensin II inhibits chemokine CCL5 expression in vascular smooth muscle cells from spontaneously hypertensive rats

Abstract 394: Chronic Knockdown of the NTS AT1R Increases Circulating Inflammatory-Endothelial Progenitor Cells Ratio and Exacerbates Hypertension in the SHR

[Effect of PP60c-Src on Angiotensin II-induced Signal Transduction in Rat Vascular Smooth Muscle Cells].

Regulation of scavenger receptor class BI gene expression by angiotensin II in vascular endothelial cells.

Effects Of Cytokines On The Expression Of Angiotensin Ii Type 1 Receptors In Vascular Smooth Muscle Cells

Angiotensin II Inhibits the Protein Expression of ZO‑1 in Vascular Endothelial Cells by Downregulating VE‑cadherin

Angiotensin II Induces Vascular Cell Adhesion Molecule-1 Expression in Rat Vasculature

Angiotensin Ii Induces Vascular Cell Adhesion Molecule-1 Expression In Rat Vasculature - A Potential Link Between The Renin-Angiotensin System And Atherosclerosis

Angiotensin II induces the expression of c-reactive protein via MAPK-dependent signal pathway in U937 macrophages.

[Angiotensin II Increases the Expression of Lectin-Like Oxidize Low-Density Lipoprotein Receptor- 1 in Cultured Human Umbilical Vein Endothlial Cells]

Effects of Cytokines on Expression of Angiotensin Ⅱ Type 1 Receptors in Vascular Smooth Muscle Cells in Rats

Angiotensin-(1–7) Regulates Angiotensin II-induced VCAM-1 Expression on Vascular Endothelial Cells

Angiotensin II induces C-reactive protein expression through ERK1/2 and JNK signaling in human aortic endothelial cells.

S-19-3: ANGIOTENSIN II REDUCES THE EXPRESSION OF CX43 AND INHIBITS THE C-SRC /MAPK/ERK PATHWAY VIA CX43 IN CARDIOMYOCYTES

Angiotensin Ii-Induced C-Reactive Protein Generation: Inflammatory Role of Vascular Smooth Muscle Cells in Atherosclerosis

[Effects of Angiotensin II on Extracellular Signal-Regulated Protein Kinases Signaling Pathway in Cultured Vascular Smooth Muscle Cells from Wistar-Kyoto Rats and Spontaneously Hypertensive Rats].

ERK1/2 and SAPK/JNK signaling pathways mediate Ang II-induced rat vascular smooth muscle cells proliferation via monocyte chemoattractant protein-1 expression

Angiotensin II Induces Inflammatory Response Partly Via Toll-Like Receptor 4-Dependent Signaling Pathway in Vascular Smooth Muscle Cells.

1010 MONOCYTE CHEMOATTRACTANT PROTEIN-1 MEDIATES ANGIOTENSIN II-INDUCED VASCULAR SMOOTH MUSCLE CELL PROLIFERATION VIA SAPK/JNK AND ERK1/2

Hypoxia inducible factor 1α in vascular smooth muscle cells promotes angiotensin II-induced vascular remodeling via activation of CCL7-mediated macrophage recruitment.

DIFFERENT EFFECTS OF ANGIOTENSIN II AND ANGIOTENSIN-(1–7) ON ENDOTHELIAL VCAM-1 EXPRESSION DURING ATHEROSCLEROSIS